| ACPA | anti-citrullinated protein antibodies |
| APS | antiphospholipid syndrome |
| AS | atherosclerosis |
| DMARD | disease-modifying antirheumatic drugs |
| bDMARDs | biologic disease-modifying antirheumatic drugs |
| CAD | coronary artery disease |
| CRP | C-reactive protein |
| CVD | cardiovascular disease |
| DM | diabetes mellitus |
| EBV | Epstein-Barr virus |
| EULAR | European Alliance of Associations for Rheumatology |
| FLS | fibroblast-like synoviocytes |
| HDL | high-density lipoprotein |
| ICAM-1 | intercellular adhesion molecule-1 |
| IL-1 | interleukin-1 |
| IL-1β | interleukin-1 beta |
| IL-6 | interleukin-6 |
| LDL | low-density lipoprotein |
| MMPs | matrix metalloproteinases |
| MRI | magnetic resonance imaging |
| NF-κB | kappa-light-chain-enhancer of activated B cells |
| NSAIDs | nonsteroidal anti-inflammatory drugs |
| OA | osteoarthritis |
| RA | rheumatoid arthritis |
| RF | rheumatoid factor |
| SLE | systemic lupus erythematosus |
| TENS | transcutaneous electrical nerve stimulation |
| TNF-α | factor-alpha |
| VCAM-1 | vascular cell adhesion molecule-1 |
| WHO | World Health Organization |